Clinical trials for Diabetic Atherosclerosis are an important part of Diabetic research and can lead to more affective Diabetic treatment to avoid Atherosclerosis and understanding of the conditions that contribute to it, such as poor blood sugar management, high cholesterol, or ineffective Diabetes diet or Diabetes medication .

ACCORD-MIND: Action to Control Cardiovascular Risk in Diabetes--Memory in Diabetes
ACCORD-MIND: Action to Control Cardiovascular Risk in Diabetes--Memory in Diabetes November 9, 2008 Clinicaltrials.gov This study is ongoing, but not recruiting participants. Sponsors and C
ACCORD-MIND: Action to Control Cardiovascular Risk in Diabetes--Memory in Diabet...
Crestor Effective at Halting Early Atherosclerosis
Crestor Effective at Halting Early Atherosclerosis www.dlife.com March 25, 2007 March 25, 2007 (EurekAlert) – An international study using ultrasound technology has found that the most potent
http://www.dlife.com/diabetes-news/2007/03/crestor...
Diabetic Under 70 (Diabetics Below 70)
Diabetic Under 70 (Diabetics Below 70) This study is currently recruiting participants. Verified by AstraZeneca, August 2007 Sponsored by: AstraZeneca Information provided by: AstraZeneca
http://www.clinicaltrials.gov/ct2/show/NCT00516204...
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial clinicaltrials.gov This study has been completed. Sponsored by: Kumamoto University Information provi
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) ...
PIoglitazone for PrEvention of Restenosis in Diabetic Patients
PIoglitazone for PrEvention of Restenosis in Diabetic Patients This study is currently recruiting participants. Verified by University of Rome Tor Vergata, June 2008 Sponsored by: University of R
http://www.clinicaltrials.gov/ct2/show/NCT00376870...
Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
Background Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to deter
Rationale and protocol of a trial for prevention of diabetic atherosclerosis by ...
Stop Atherosclerosis in Native Diabetics Study (SANDS)
Stop Atherosclerosis in Native Diabetics Study (SANDS) clinicaltrials.gov This study has been completed. Sponsored by: National Heart, Lung, and Blood Institute (NHLBI) Information prov
http://clinicaltrials.gov/ct2/show/NCT00047424
Why does diabetes increase atherosclerosis? I don’t know!
Why does diabetes increase atherosclerosis? I don’t know! www.jci.org Published in Volume 114, Issue 5 (September 1, 2004) J. Clin. Invest. 114(5): 613-615 (2004). doi:10.1172/JCI22826. Cop
http://www.jci.org/articles/view/22826/version/1